Literature DB >> 23290446

Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women.

Robert P Fellows1, Desiree A Byrd, Susan Morgello.   

Abstract

Major depressive disorder (MDD), cognitive symptoms, and mild cognitive deficits commonly occur in HIV-infected individuals, despite highly active antiretroviral therapies. In this study, we compared neuropsychological performance and cognitive symptoms of 191 HIV-infected participants. Results indicated that participants with a formal diagnosis of current MDD performed significantly worse than participants without MDD in all seven neuropsychological domains evaluated, with the largest effect sizes in information processing speed, learning, and memory. In addition, a brief assessment of cognitive symptoms, derived from a comprehensive neuromedical interview, correlated significantly with neurocognitive functioning. Participants with MDD reported more cognitive symptoms and showed greater neurocognitive deficits than participants without MDD. These findings indicate that HIV-infected adults with MDD have more cognitive symptoms and worse neuropsychological performance than HIV-infected individuals without MDD. The results of this study have important implications for the diagnosis of HIV-associated neurocognitive disorders (HAND).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290446      PMCID: PMC3785228          DOI: 10.1017/S1355617712001245

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  57 in total

Review 1.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.

Authors:  Sibel Tekin; Jeffrey L Cummings
Journal:  J Psychosom Res       Date:  2002-08       Impact factor: 3.006

2.  Age difference in rates of mental health/substance abuse and behavioral care in HIV-positive adults.

Authors:  Faika Zanjani; Kirsten Saboe; David Oslin
Journal:  AIDS Patient Care STDS       Date:  2007-05       Impact factor: 5.078

3.  Clinical Markers of the Presence of Dementia and Neuropsychological Impairment in HIV Infection.

Authors:  N Dunbar; L Pemberton; M Perdices; B J Brew
Journal:  J NeuroAIDS       Date:  1996

4.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

5.  Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals.

Authors:  B C Bix; G Glosser; W Holmes; C Ballas; M Meritz; C Hutelmyer; J Turner
Journal:  J Int Neuropsychol Soc       Date:  1995-11       Impact factor: 2.892

6.  Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings.

Authors:  Y Stern; K Marder; K Bell; J Chen; G Dooneief; S Goldstein; D Mindry; M Richards; M Sano; J Williams
Journal:  Arch Gen Psychiatry       Date:  1991-02

7.  The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples.

Authors:  Michael C Diehr; Mariana Cherner; Tanya J Wolfson; S Walden Miller; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2003-06       Impact factor: 2.475

Review 8.  Antidepressants for neuropathic pain.

Authors:  T Saarto; P J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus.

Authors:  R L Mapou; W A Law; A Martin; D Kampen; A M Salazar; J R Rundell
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

10.  Quality of life and immune activation in patients with HIV-infection.

Authors:  K Schroecksnadel; M Sarcletti; C Winkler; B Mumelter; G Weiss; D Fuchs; G Kemmler; R Zangerle
Journal:  Brain Behav Immun       Date:  2008-02-07       Impact factor: 7.217

View more
  25 in total

1.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

2.  Does Age Influence the Frequency of Anxiety Symptoms and Disorders in HIV Disease?

Authors:  Charles P Brandt; David P Sheppard; Michael J Zvolensky; Erin E Morgan; J Hampton Atkinson; Steven Paul Woods
Journal:  J HIV AIDS Soc Serv       Date:  2016-06-28

3.  Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS.

Authors:  Robert P Fellows; Desiree A Byrd; Susan Morgello
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-11       Impact factor: 2.475

4.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

5.  Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.

Authors:  Teresa H Evering; Allison Applebaum; Melissa La Mar; Donald Garmon; David Dorfman; Martin Markowitz
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

6.  Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.

Authors:  Vaughn E Bryant; Nicole E Whitehead; Larry E Burrell; Vonetta M Dotson; Robert L Cook; Paul Malloy; Kathryn Devlin; Ronald A Cohen
Journal:  AIDS Behav       Date:  2015-08

7.  Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth.

Authors:  Jennifer L McGuire; John H Kempen; Russell Localio; Jonas H Ellenberg; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2014-10-29

8.  Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.

Authors:  Tonita E Wroolie; Heather A Kenna; Katherine E Williams; Natalie L Rasgon
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-21       Impact factor: 4.105

9.  Psychological trauma exposure and co-morbid psychopathologies in HIV+Men and Women.

Authors:  Robert P Fellows; Nayeli A Spahr; Desiree A Byrd; Monica Rivera Mindt; Susan Morgello
Journal:  Psychiatry Res       Date:  2015-11-10       Impact factor: 3.222

10.  The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

Authors:  Lucette A Cysique; Nadene Dermody; Andrew Carr; Bruce J Brew; Maree Teesson
Journal:  J Neurovirol       Date:  2015-08-25       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.